Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • ADVERTISEMENT FEATURE Advertiser retains sole responsibility for the content of this article

How can we make precision medicine for lung cancer patients a reality?

TRACERx is a multimillion pound project funded by Cancer Research UK. By mapping the differences between individual cancer cells in hundreds of patients, it aims to track lung cancer evolution in unprecedented detail.

Produced by

Nature Research Custom Media
Cancer Research UK

In this video, Professor Charles Swanson describes how TRACERx is providing new insights into the forces that shape how tumours change over time, and how they interact with the body’s immune system. This knowledge could not only help us to predict which patients will respond to treatments, but also lead to the development of new cancer therapies.

This video is produced by Nature Research Custom Media for Cancer Research UK subject to a commercial agreement. It summarises recent findings of the TRACERx lung study that is funded by Cancer Research UK. A collection of TRACERx research articles published independently and further to peer-review in Nature Research journals can be accessed here.

Search

Advanced search

Quick links